NSN 6505-01-660-3315 · NIIN 016603315 · FSC 6505
NO DASHES 6505016603315
In Stock
PHENOBARBITAL SODIUM INJECTION
Drugs and Biologicals
Technical characteristics
12 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 1.0 |
| CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CSGS | ADMINISTRATION | INTRAMUSCULAR AND INTRAVENOUS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PHENOBARBITAL 130 MG/ML INJECTION, 25 VIALS PER PACKAGE |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| CBBL | FEATURES PROVIDED | STERILE |
| FEAT | SPECIAL FEATURES | EACH MILLILITER OF STERILE SOLUTION CONTAINS 130 MILLIGRAMS (MG) OF PHENOBARBITAL SODIUM FOR INTRAMUSCULAR OR SLOW INTRAVENOUS ADMINISTRATION AS A LONG-ACTING BARBITURATE; SCHEDULE IV CONTROLLED SUBSTANCE CONCENTRATION/STRENGTH: 130 MG / ML; VIAL SIZE: 2 ML; FILL VOLUME: 1 ML; STORE AT 20 TO 25 C (68 TO 77 F), (SEE USP CONTROLLED ROOM TEMPERATURE) |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS PHENOBARBITAL SODIUM ACTIVE INGREDIENT 130.0 |
| AJCN | PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |